Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Antimicrob Agents Chemother ; 56(6): 2824-30, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22371900

RESUMEN

In response to a published concern about the potency and quality of generic vancomycin products, the United States Food and Drug Administration investigated a small sampling of the vancomycin products available in North America with regard to purity, content, and potency. To facilitate identification of impurities, a new liquid chromatography method was developed using high-resolution mass spectrometry in addition to diode array detection to characterize impurities in several commercial products. Furthermore, a microbiological assay was utilized to link the analytical profiles with an in vitro potency. All products tested met the quality specifications outlined in the United States Pharmacopeia (USP) (vancomycin hydrochloride for injection monograph) for impurities and potency (USP, Vancomycin hydrochloride for injection. United States Pharmacopeia and National Formulary, vol USP 34-NF 29, 2011).


Asunto(s)
Cromatografía Liquida/métodos , Espectrometría de Masas/métodos , Seguridad de Productos para el Consumidor , Control de Calidad , Estados Unidos , Vancomicina
2.
J Chromatogr A ; 1217(48): 7547-55, 2010 Nov 26.
Artículo en Inglés | MEDLINE | ID: mdl-20980012

RESUMEN

A high-pressure liquid chromatography-diode array detection and multi-mode ionization tandem mass spectrometry (HPLC-DAD-MMI-MS/MS) method was used to identify amino-tadalafil and rimonabant in electronic cigarette (e-cigarette) cartridges. Amino-tadalafil is a drug analogue of the commercially approved Cialis™ (i.e. tadalafil). Rimonabant is a drug that was, at one time, approved for weight loss in Europe (although approval has been retracted), but not in the United States. In addition, poor quality control over the e-cigarette products analyzed here is shown by the presence of nicotine in products labeled as containing no nicotine or by the presence of significant amounts of rimonabant oxidative degradant in e-cigarette products containing rimonabant. Identification was accomplished by comparing the retention time of relevant peaks in the sample with those of standard compounds, in addition to comparison of the UV spectra, mass spectra and/or product ion mass spectra.


Asunto(s)
Carbolinas/análisis , Cromatografía Líquida de Alta Presión/métodos , Piperidinas/análisis , Pirazoles/análisis , Espectrometría de Masas en Tándem/métodos , Tabaco sin Humo/análisis , Rimonabant , Tadalafilo , Espectrometría de Masas en Tándem/instrumentación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA